Hims & Hers stock falls 51% amid acquisition speculation
Hims & Hers shares have declined approximately 51% over the past year to a market capitalization of roughly $7.2 billion following a Q1 2026 revenue miss and gross margin compression to 65%.
Retail health platforms, pharmacy automation, in-store clinics, consumer health distribution.
Hims & Hers shares have declined approximately 51% over the past year to a market capitalization of roughly $7.2 billion following a Q1 2026 revenue miss and gross margin compression to 65%.
Hims & Hers is expected to complete its $1.15 billion acquisition of Eucalyptus in mid-2026, a move that signals a strategic pivot toward international platform expansion.
The U.S. retail clinics market is forecast to grow at an 11.1% CAGR during 2026–2033, reaching $6.29B by 2033.
Digital commerce platforms are reducing eyewear costs by at least 40% compared to in-retail options, yet in-person exams remain the preferred method for many consumers seeking healthcare access.
Swedish health-tech company Neko Health secured a $700 million Series C round led by Lightspeed and O.G. Venture Partners to expand into the United States with AI-powered preventive health scan clinics.
A September 2025 government memo introduced new restrictions on direct-to-consumer pharmaceutical advertising following earlier executive orders promoting DTC sales.
Major retailers are integrating clinical services such as weight-loss clinics and in-store diagnostics into their physical locations.
The central-fill pharmacy automation market is projected to reach approximately $790 million in 2026, driven by labor shortages and traceability regulations.
A Placer.ai study indicates that grocery stores with integrated clinics see higher visit volumes, with specific chains reporting double-digit to triple-digit lifts in foot traffic.
Queue has emerged from stealth to launch a fully autonomous robotic pharmacy system that reduces fulfillment costs by up to 96%, with a major national pharmacy chain secured as a customer.
Carlyle Group provided capital to VLCC to accelerate the growth of its retail clinic network, with a target of reaching 175 sites by the end of 2025.
A recent report indicates that 45% of consumers sought retail clinic care in 2022, with 83% expressing a desire for health and wellness services at their pharmacy.
Queue has emerged from stealth with a robotic pharmacy system that produces filled, verified prescription vials for approximately 250 common U.S. medications with minimal human intervention.
Humana and CenterWell announced plans to open 23 senior-focused primary care clinics within Walmart Supercenters in Florida, Georgia, Missouri, and Texas.
Morrison has launched Fillex, a national automated pharmacy infrastructure platform funded via the Morrison Value Add II SCSp vehicle, signaling a shift toward treating pharmacy automation as core healthcare logistics infrastructure.
The global healthcare e-commerce market is projected to grow from $499.71 billion in 2025 to $587.05 billion in 2026, reaching $1.12 trillion by 2030.
Major retailers are restructuring their in-store healthcare operations, with some exiting clinical care or impairing assets while others expand primary care networks through health-system partnerships.
Sycamore Partners is in discussions to acquire Walgreens Boots Alliance, with a potential restructuring into three distinct entities.
Amazon Pharmacy is expanding its same-day delivery network to reach 45% of U.S. customers by late 2025 while introducing a new support feature for Medicare Part D patients.
Elevance Health is purchasing Kroger's specialty pharmacy division to integrate retail distribution with payer-sponsored clinical services.
The global market for automated pharmacy compounding systems is projected to grow from USD 2.95 billion in 2025 to USD 5.27 billion by 2035, with North America holding 40% of the market share in 2024.
NielsenIQ reports that health and wellness products are now embedded across the omnichannel retail journey, driving broader category growth and self-directed consumer behavior.
Modernizing Medicine secured a majority investment from Clearlake Capital in 2025 at a $5.3 billion valuation.
Foundation Health has secured $20 million in funding to implement AI-driven operational improvements for brick-and-mortar retail pharmacies, focusing on patient experience and backend efficiency.
Queue has secured $12.6 million to launch fully autonomous robotic pharmacy kiosks designed to increase prescription accessibility by reducing labor constraints in retail settings.
Retail health operators are increasingly relying on partnerships with specialized medical providers to expand in-store clinic services and manage value-based care.
The closure of hundreds of standalone retail clinics is driving the industry to pivot from independent expansion to strategic collaborations with established health systems.